Lableader 3D bioprinting and biohybrid microsystems
The vision the 3D Bioprinting Group is to build cell-based biohybrid systems aimed for organs-on-chips as well as for implants aimed to enable personalized therapies/drugs and promote preventive healthcare respectively. With this goal in mind, the 3D Bioprinting Group was able to strengthen and prove its competences in the following fields:
3D Bioprinting
- Bioprinting of vascularized and innervated thick tissues.
- Toxicological assays (body on chip, 3R Animal Free Research).
- Cell and extracellular matrix based functional micro implants.
- Cell-laden hydrogels, single and multicellular.
- Bioinert support materials.
- Ceramics for dental implants.
- Modelling, simulation and validation of 3D printing processes.
Biohybrid Microsystems
- Cell based micro robotics.
- Bioengineered neuromuscular junctions.
